Ayalon Insurance has delivered a very large 3 year share price gain, which naturally raises a valuation question for anyone looking at the stock today. The issue is whether that performance is backed up by the returns the insurer earns on the capital it deploys.
-
Over the past 3 years the share price has climbed about 13x, which puts a lot of weight on the quality and durability of the returns the business generates on its capital base.
-
A possible acquisition of CAL Israel Credit Cards may reshape how Ayalon uses its balance sheet, which can affect future capital needs, profit mix and the returns earned on each shekel reinvested.
-
If you'd rather focus on earnings, this one's for you. See what Ayalon Insurance's 11.5x P/E says about the price .
The stock's next move may depend on whether the returns Ayalon Insurance earns on its capital are strong enough to support where the share price sits now.
If you want to test the same capital returns question across other companies rather than only Ayalon Insurance, run the our screener containing 613 high quality undiscovered gems
Where Does Ayalon Insurance Sit on Excess Returns?
The Excess Returns model values Ayalon Insurance by asking how much profit it can earn above its cost of equity on each shekel of shareholder capital. On the model's inputs, Ayalon is assumed to generate stable earnings of ₪10.04 per share on a stable book value base of ₪43.78 per share, with that earnings figure anchored to the median return on equity from the past 5 years. With a cost of equity of ₪3.74 per share and an excess return of ₪6.30 per share, the framework implies that the business is modeled to earn more on its equity than the return investors are assumed to require.
An average return on equity of 22.94% and a calculated book value of ₪63.05 per share are paired with a dividend profile that assumes ongoing growth of 3.6% and a payout ratio of 34.38%. That dividend discount setup produces an internal value estimate per share that leaves the Excess Returns result broadly in line with the current share price of ₪178.60, so the market is treating those modeled excess profits as reasonably durable. Because the potential CAL Israel Credit Cards acquisition could reshape how capital is deployed and earned, the alignment between model and market hinges on whether future returns on equity stay close to these assumptions. Find out what Ayalon Insurance could be worth using our Excess Returns estimate .
The Ayalon Insurance Narrative: What Would Justify Today's Price?
Narratives for Ayalon Insurance pick up where this valuation puzzle leaves off, by spelling out which paths for future growth, margins and earnings would need to play out for the shares to be worth meaningfully more or less than today's level. Each scenario ties a fair value estimate to a clear set of potential catalysts and risks around Ayalon Insurance's business, so you can track over time which version of events appears to be unfolding.
A clear, number-driven narrative on Ayalon Insurance sets out the earnings, book value and return assumptions in black and white, so you can see exactly what has to happen for the current share price to make sense. With the potential CAL Israel Credit Cards acquisition on the table, that kind of written roadmap also gives you a reference point to judge over time whether the deal, if it proceeds, actually supports the returns that are currently being priced in.
Share your own Narrative for Ayalon Insurance and set out the assumptions behind your valuation.
One last Ayalon Insurance check that belongs beside the share price chart
Sharp share moves and modeled returns only tell part of the story for Ayalon Insurance, because separate research checks have raised specific concerns that deserve a closer look before you weigh the opportunity. Take a closer look at 1 warning sign before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AYAL.TA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
